Rocket Science Health validates targeted olfactory-cleft deposition in non-human primates ahead of the 4th Nasal Formulation & Delivery Summit
Sanatate
From Hanson Wade Group - 4th Nasal Formulation & Delivery Summit May 15 2026 As the pace of modern drug discovery accelerates, the industry is increasingly recognizing that a breakthrough molecule is only as effective as its ability to reach the target site. Nowhere is this challenge more acute than in treating Central Nervous System (CNS) and brain-related illnesses, where the blood-brain barrier remains a formidable obstacle to traditional delivery. Today, the "how" of drug delivery is
din zilele anterioare